HIF-2 alpha inhibitors are transforming therapy for patients with renal cell carcinoma and von Hippel-Lindau disease. Sean Korbitz had his first bout with cancer — a brain tumor discovered after six ...
Lana Hallowes has spent most of her life in hospital, diagnosed with Von Hippel Lindau disease at just 11 years old. “I’ve ...
BOSTON, Mass. (Ivanhoe Newswire) - Von Hippel-Lindau disease is an inherited condition named after the two European scientists who discovered it. VHL puts people at higher risk of cancerous and benign ...
The cause of von Hippel–Lindau disease is excess activity of the HIF-2α pathway. A total of 61 patients with renal cell carcinoma and other proliferative manifestations of the hypoxia-induced ...
Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with ...
NEW YORK (WABC) -- Manuel Greco has Von Hippel-Lindau disease. It's a rare condition that causes tumors to grow in certain parts of the body. Most of the tumors are benign but they often grow back ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results